SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 44,550
+700 (1.60%)
At close: Apr 16, 2026
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.5 trillion as of April 16, 2026. Its market cap has increased by 5.58% in one year.
Market Cap
3.50T
Enterprise Value
3.32T
Revenue
651.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
44,550.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.50T, a decrease of -72.90%. That is a compound annual growth rate of -22.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 3.44T | -8.95% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 7.75T |
| SK Biopharmaceuticals | 7.73T |
| LigaChem Biosciences | 6.88T |
| Peptron | 6.06T |
| Voronoi | 5.34T |
| D&D Pharmatech | 3.35T |
| OliX Pharmaceuticals | 3.28T |
| PharmaResearch | 3.08T |